packageNaproxcinod

naproxcinod

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Naproxcinod, a nitric oxide–donating derivative of naproxen, was developed as a non-steroidal anti-inflammatory drug for treating inflammatory and rheumatic conditions. It remained investigational and was never marketed; its marketing application in the European Union was withdrawn.

Summary written by glm-5.3-flash from Wikidata Q3335996 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:naproxcinod
ATC codes:M01AE18
DrugBank:DB06682
PubChem CID:9884642
ChEBI:76254
Wikidata:Q3335996
formula:C18H21NO6
molar mass:347.367 g/mol (PubChem CID 9884642)
logP:4.1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown